Last reviewed · How we verify
NCT05466292: Val_CEC
Evaluating a Clinical Ethics Committee (CEC) Implementation Process
trial testing Survey1 in Service Evaluation in 20 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2023
Quick facts
| Lead sponsor | Azienda USL Reggio Emilia - IRCCS |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 4 July 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 30 December 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Survey1
- semi-structured interview_1
- semi-structured interview_2
- semi-structured interview_3
- survey_2
Conditions studied
- Service Evaluation — all drugs for Service Evaluation →
Sponsor
Azienda USL Reggio Emilia - IRCCS — full company profile →
Who can join
Adults 18 to 75, any sex, with Service Evaluation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a Mixed-method study with retrospective quantitative assessment and prospective qualitative evaluation focused on the development and implementation of a multidisciplinary Clinical Ethics Committee (CEC), 16 months from its implementation. A CEC is a multi-professionals service that aims to support healthcare professionals (HPs) and healthcare organizations in dealing with ethical issues of clinical practice, providing also ethics consultations (EC) for complex clinical cases, characterized by conflicting ethical perspectives. In 2020, a CEC was established in an Oncology Research Hospital in the North of Italy. It was developed and implemented according to the Medical Research Council (MRC) framework for developing and evaluating complex interventions. The purpose of this study is to evaluate the CEC's development and implementation process, after 16 months it entered into force. Study's hypothesis: the investigators expect to identify the relevant components that contribute to the CEC's successful implementation and integration into everyday practice. Findings would also identify required modifications to improve the service and develop practical strategies for enabling and sustaining the CEC delivery in clinical settings.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluating a clinical ethics committee (CEC) implementation process in an oncological research hospital: protocol for a process evaluation study using normalisation process theory (EvaCEC).
Perin M, Magelssen M, Ghirotto L, De Panfilis L. · · 2023 · cited 2× · PMID 36894200 · DOI 10.1136/bmjopen-2022-067335 -
How to implement a clinical ethics committee in an oncological research hospital: Qualitative results from a process evaluation study using normalization process theory (EVACEC).
Perin M, Magelssen M, Crico C, Ghirotto L, et al · · 2025 · PMID 40327687 · DOI 10.1371/journal.pone.0318870
Verify or expand the search:
- PubMed search for NCT05466292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Survey1
Trials testing the same drug.
- NCT05997368 — Investigation of the Relationship of Pain Perception and Pain Belief With Age in People With Chronic Lack Pain · completed
Other Azienda USL Reggio Emilia - IRCCS trials
Trials by the same sponsor.
- NCT07373626 — Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic · recruiting
- NCT07000162 — LAttice Radiation Therapy for Large Lesions: Reggio Emilia Single-arm Phase II Trial · Phase 2 · recruiting
- NCT06629896 — Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomize · NA · recruiting
- NCT06749600 — Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma · recruiting
- NCT06624280 — Does Orthopedic Surgery Improve Gait Efficiency in Children With Cerebral Palsy? A Retrospective Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05466292 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda USL Reggio Emilia - IRCCS
- Last refreshed: 24 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05466292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing